SPG302 / Spinogenix  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SPG302 / Spinogenix
NCT05882695: Study of SPG302 in Healthy Volunteers and ALS Participants

Recruiting
1
112
US, RoW
SPG302, Placebo
Spinogenix, Novotech (Australia) Pty Limited
Amyotrophic Lateral Sclerosis
05/25
12/25

Download Options